51. Malignant mesothelioma, are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio prognostic indicator parameters as reliable?
- Author
-
Levent Dalar, Seda Tural Önür, Sinem Nedime Sökücü, Songül Büyükkale, Kaan Kara, and Sedat Altin
- Subjects
medicine.medical_specialty ,Pathology ,medicine.diagnostic_test ,business.industry ,Disease stages ,Lymphocyte ,Complete blood count ,medicine.disease ,Gastroenterology ,medicine.anatomical_structure ,Internal medicine ,medicine ,Mesothelioma ,Prospective cohort study ,business ,Area under the roc curve ,Platelet lymphocyte ratio - Abstract
Background and aim: Malignant Mesothelioma is aggressive pleural tumors. We need an easily accessible, inexpensive and reliable method for determining low survival time prognosis of this tumor. The aim of our study investigate neutrophil / lymphocyte ratio and platelet / lymphocyte ratio as a prognostic indicator of the availability. Materials and methods: Thirty six malignant mesothelioma patients, whose histopathologic diagnosis was established and followed by our clinic, accesible to complete archive data were included. Our study is designed as a retrospective. Patients9 histopathological types, disease stages, a complete blood count parameters at diagnosis and survival were recorded. Results: Eighteen of Malignant mesothelioma patients were male and average follow-up period was 24.83 ± 3.61 months. PLR levels of patients according to mortality varies statistically significant (p
- Published
- 2015
- Full Text
- View/download PDF